# Lung Impedance Monitoring In Treatment of Chronic Heart Failure

> **NCT01320007** · NA · COMPLETED · sponsor: **Barts & The London NHS Trust** · enrollment: 80 (actual)

## Conditions studied

- Heart Failure

## Interventions

- **DRUG:** Preset increase in frusemide dose
- **OTHER:** No intervention

## Key facts

- **NCT ID:** NCT01320007
- **Lead sponsor:** Barts & The London NHS Trust
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-09
- **Primary completion:** 2014-10
- **Final completion:** 2014-12
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2015-07-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01320007

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01320007, "Lung Impedance Monitoring In Treatment of Chronic Heart Failure". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01320007. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*